ADJUVANT CHEMO-IMMUNOTHERAPY AND IMMUNOTHERAPY IN DUKES STAGE-B2 AND STAGE-C COLORECTAL-CARCINOMA - A 7-YEAR FOLLOW-UP ANALYSIS

被引：12

作者：

ABDI, EA

HANSON, J

HARBORA, DE

YOUNG, DG

MCPHERSON, TA

机构：

[1] CROSS CANC INST,DEPT MED,EDMONTON T6G 1Z2,ALBERTA,CANADA

[2] CROSS CANC INST,DEPT EPIDEMIOL & BIOSTAT,EDMONTON T6G 1Z2,ALBERTA,CANADA

[3] UNIV ALBERTA,EDMONTON T6G 2E1,ALBERTA,CANADA

[4] MISERICORDIA HOSP,DEPT PATHOL,EDMONTON,ALBERTA,CANADA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 1989年 / 40卷 / 03期

关键词：

D O I：

10.1002/jso.2930400315

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：205 / 213

页数：9

共 39 条

[1] THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM [J].

ASTLER, VB ;

COLLER, FA .

ANNALS OF SURGERY, 1954, 139 (06) :846-852

[2] LEUKEMIA AND PRELEUKEMIA AFTER ADJUVANT TREATMENT OF GASTROINTESTINAL CANCER WITH SEMUSTINE (METHYL-CCNU) [J].

BOICE, JD ;

GREENE, MH ;

KILLEN, JY ;

ELLENBERG, SS ;

KEEHN, RJ ;

MCFADDEN, E ;

CHEN, TT ;

FRAUMENI, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (18) :1079-1084

[3]

CARTER SK, 1976, CANCER IMMUNOL IMMUN, V1, P199

[4]

DCL, 1985, ANN REPORT

[5]

DEVITA VT, 1977, ADJUVANT THERAPY CAN, P613

[6]

DUKES CE, 1932, J PATHOL BACTERIOL, V35, P1489

[7]

EISENBERG B, 1982, CANCER, V49, P1131, DOI 10.1002/1097-0142(19820315)49:6<1131::AID-CNCR2820490611>3.0.CO

[8]

2-T

[9]

FALK RE, 1973, ARCH SURG-CHICAGO, V107, P261

[10]

FALKSON G, 1976, CANCER-AM CANCER SOC, V38, P1468, DOI 10.1002/1097-0142(197610)38:4<1468::AID-CNCR2820380403>3.0.CO

← 1 2 3 4 →